Skip to main content
Fig. 1 | Acta Neuropathologica Communications

Fig. 1

From: Targeted deletions of complement lectin pathway genes improve outcome in traumatic brain injury, with MASP-2 playing a major role

Fig. 1

Experimental design. a WT or KOs mice (including: MASP-2−/−, MBL−/−, FCN-A−/−, CL-11−/−, MBL-C−/−, MASP-1/3−/− and MBL-A−/−) were subjected to TBI or sham injury. Sensorimotor deficits were assessed weekly by neuroscore and beam walk test. The sum of 4-week performances of each mouse genotype has been used to calculate the health score. b MBL brain presence and residual LP activity in plasma was assed in MASP-2−/− and WT TBI mice 30′ after surgery. Histopathological analysis was done for MASP-2−/− and WT mice at 6 weeks after TBI

Back to article page